Alector (ALEC) EBT Margin (2018 - 2026)

Alector (ALEC) reported EBT Margin of 2192.16% for Q1 2026, down 109061.0% year-over-year from N/an in Q1 2025, and down 268.54% quarter-over-quarter from 594.82% in Q4 2025.

Alector (ALEC) EBT Margin (2018 - 2026) Analysis & Trends

Alector (ALEC) has 9 years of EBT Margin data on file, last reported at 2192.16% in Q1 2026.

  • EBT Margin for Q1 2026 came in at 2192.16%, down 109061.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 679.92% (down 54032.0% YoY), and the FY2025 annual result was 678.36%, down 56010.0% from the prior year.
  • EBT Margin fell to 2192.16% in Q1 2026 per ALEC's latest filing, from 594.82% in the prior quarter.
  • Over five years, EBT Margin peaked at 13.68% in Q2 2022 and troughed at 2192.16% in Q1 2026.
  • A 5-year average of 466.7% and a median of 275.19% in 2024 frame the typical range for EBT Margin.
  • The sharpest annual moves came in 2022 and 2026: EBT Margin jumped 109016 bps in 2022, then sank 109061 bps in 2026.
  • A 5-year view of EBT Margin shows it stood at 358.08% in 2022, then rose by 27 bps to 261.8% in 2023, then soared by 99 bps to 3.74% in 2024, then tumbled by 15825 bps to 594.82% in 2025, then sank by 269 bps to 2192.16% in 2026.
  • Business Quant data shows ALEC's EBT Margin at 2192.16% in Q1 2026, 594.82% in Q4 2025, and 1063.4% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 6.40%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 41.95%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Alector 193.53 Mn -12.98 Mn - -2,192.16%

Historic Data

Download Data
DateValue
Mar 31, 2026 -2,192.16%
Dec 31, 2025 -594.82%
Sep 30, 2025 -1,063.40%
Jun 30, 2025 -387.66%
Mar 31, 2025 -1,101.55%
Dec 31, 2024 -3.74%
Sep 30, 2024 -275.19%
Jun 30, 2024 -255.94%
Mar 31, 2024 -226.97%
Dec 31, 2023 -261.80%
Sep 30, 2023 -474.51%
Jun 30, 2023 4.92%
Mar 31, 2023 -271.65%
Dec 31, 2022 -358.08%
Sep 30, 2022 -305.78%
Jun 30, 2022 13.68%
Mar 31, 2022 -179.21%
Dec 31, 2021 -397.37%
Sep 30, 2021 69.40%
Jun 30, 2021 -839.63%